Ipratropium bromide and Eczema - a phase IV clinical study of FDA data

Summary:

Eczema is reported as a side effect among people who take Ipratropium bromide (ipratropium bromide), especially for people who are female, 60+ old, also take Gabapentin, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Eczema when taking Ipratropium bromide. It is created by eHealthMe based on reports of 17,749 people who have side effects when taking Ipratropium bromide from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Eczema?

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters) is found to be associated with 1,497 drugs and 1,942 conditions by eHealthMe. Check the latest studies of Eczema.

On Jul, 06, 2026

17,749 people reported to have side effects when taking Ipratropium bromide.
Among them, 55 people (0.31%) have Eczema.

Among these 55 people:

What is the gender of people who have Eczema when taking Ipratropium bromide? *

female: 78.18 %
male: 21.82 %

What is the age of people who have Eczema when taking Ipratropium bromide? *

What are other drugs people take besides Ipratropium bromide? *

What are other side effects people have besides Eczema? *

Dyspnea (difficult or laboured breathing): 22 people, 40.00%
Headache (pain in head): 19 people, 34.55%
Wheezing (a high-pitched whistling sound made while you breath): 19 people, 34.55%
Pain: 18 people, 32.73%
Weakness: 17 people, 30.91%
Fever: 17 people, 30.91%
Fatigue (feeling of tiredness): 16 people, 29.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 27.27%
Stress And Anxiety: 15 people, 27.27%
Pneumonia: 15 people, 27.27%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 8 people, 14.55%
Immunodeficiency Common Variable: 4 people, 7.27%
Stress And Anxiety: 4 people, 7.27%
Seasonal Allergy (allergic condition due to certain season): 4 people, 7.27%
Pain: 2 people, 3.64%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 3.64%
High Blood Pressure: 2 people, 3.64%
Sinus Disorder (disease of sinus): 2 people, 3.64%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 3.64%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 3.64%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and have Eczema?

- Check whether Eczema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ipratropium bromide:

Ipratropium bromide (17,965 reports)

Eczema treatments and more:

Eczema (61,311 reports)

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eczema:

Eczema (1,497 drugs)

Browse all the conditions that are associated with Eczema:

Eczema (1,942 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide (the active ingredients of Ipratropium bromide) and Ipratropium bromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.